Narcotic Use in Pregnancy: Risks to Mother and Fetus

No opioid (narcotic) is considered safe for routine use in pregnancy. All cross the placenta and affect the fetus.

Maternal Risks

  • Respiratory depression, sedation, constipation, ileus.
  • Opioid use disorder (OUD), overdose.
  • Obstetric: Prolonged labor, instrumental delivery, postpartum hemorrhage.

Fetal/Neonatal Risks

  • NAS/NOWS: Neonatal abstinence/opioid withdrawal syndrome (tremor, irritability, feeding difficulty, seizures) in 50–80% of exposed infants; requires pharmacologic treatment (morphine, methadone, buprenorphine).
  • Preterm birth, low birth weight, SGA.
  • Birth defects: Possible association with neural tube defects, cardiac anomalies (codeine, oxycodone); data conflicting.
  • Stillbirth: Increased risk with chronic use.
  • Neurodevelopment: Potential long-term cognitive/behavioral effects.

Clinical Approach

  • Acute pain: Short-course, lowest effective dose; multimodal (acetaminophen, regional anesthesia).
  • Chronic pain/OUD: Medication for OUD (MOUD)—methadone or buprenorphine—improves outcomes vs. detox. Continue through pregnancy/postpartum.
  • Shared decision-making: Risks of untreated pain/OUD vs. medication exposure.
  • Breastfeeding: Compatible with MOUD; low milk levels; benefits outweigh risks.

Multidisciplinary care (OB, addiction, pediatrics, social work) optimizes maternal-infant health.

Pregnancy & Health - Related Articles